Contineum’s PIPE-307 Fails Phase II MS Trial, Focus Shifts To IPF Candidate

 
• By Sushmita Panda
  
A doctor hold a holographic image of brain in his hand.
Multiple sclerosis (MS) is an inflammatory disease affecting the brain and spinal cord of the Central Nervous System (CNS).

More from Clinical Trials

More from R&D